---

Cancer Types

Types of Cancer > Brain Tumors > Treatment Options

Treatment Options

Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

Podcast from Opportunities in Proton Therapy: Chordoma/Chondrosarcoma

Podcast from Opportunities in Proton Therapy: Craniopharyngioma

Chemotherapy

"Cereport" Treatment for Astrocytoma

7th National Brain Tumor Conference

7th National Brain Tumor Conference

A Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma

A Multicenter, Randomized, Double Blind, Placebo (PB) Controlled Trial of Marimastat (MT) In Patients with Glioblastoma Multiforme (GBM) or Gliosarcoma (GS) Following Completion of Conventional, First-Line Treatment

A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

A Phase II Randomized Trial of Synchronous Radiotherapy With Temozolomide in Brain Metastases

A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma: 5-year Disease Control and Functional Outcomes

A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma: 5-year Disease Control and Functional Outcomes

A Phase III Prospective Randomized Trial Comparing Radiosurgery With Versus Without Whole Brain Radiotherapy for 1-3 Newly Diagnosed Brain Metastases

ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

Brain Tumor Action Week Symposium

Brain tumors & choosing a cancer center

Brain Tumors, High Tension Wires and Other Risk Factors

Brain Tumors: Confronting the Challenge Together

Chemotherapy for Brain Tumors

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM).  Conclusive results of a radomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.

Development of Glioblastoma Multiforme

Dose Escalation in Pediatric Brain Tumors with Radiation Therapy. A dosimetric Evaluation on The Potential Role of Proton Beam Therapy

Extent of Surgical Resection Predicts a Favorable Outcome for Children with Malignant Gliomas

Hereditary Brain Cancer and Glioblastoma Multiforme

Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

Interim report of the JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1-4 brain metastases.

Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone

Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone

Long-Term Neurological Outcome of Childhood Brain Tumors Treated by Surgery Only

Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial.

Motexafin Gadolinium (MGd) Combined With Prompt Whole Brain Radiation Therapy Prolongs Time to Neurologic Progression in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases: Results of a Randomized Phase 3 Trial

Motexafin gadolinium (MGd) combined with whole brain radiation therapy prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis of two randomized phase III trials

NBTF/ALCASE Brain Metastases Patient Teleconference

Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018

Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018

New Chemotherapy Combination Causes Brain Tumors to Regress

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution

P53, EGFR, and PTEN as markers of diagnosis and prognosis in patients with anaplastic glioma enrolled in NCCTG clinical trials

Patient Summary: Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial

Phase III Trial of BCNU Plus Cisplatin (CDDP) Versus BCNU Alone, and Standard Radiation Therapy (SRT) Versus Accelerated Radiation Therapy (ART) in Glioblastoma (GBM) Patients: NCCTG/SWOG Results

Pilocytic astrocytoma

Predictors of Survival for Patients With Brain Metastases: Results of a Randomized Phase III Trial

Preliminary Report of RTOG 9508: A Phase III Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Unresected Brain Metastases

Preliminary Results from a Phase II Trial of Conformal Radiation Therapy for Localized Pediatric Brain Tumors

Primary Care: Stereotactic Radiosurgery Plus Whole Brain Radiotherapy Versus Radiotherapy Alone for Patients with Multiple Brain Metastases

Prognostic Value of Initial Magnetic Resonance Imaging Growth Rates for World Health Organization Grade II Glioma

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Randomized Prospective Comparison of Stereotactic Radiosurgery (SRS) Followed by Conventional Radiotherapy (RT) with BCNU to RT with BCNU Alone for Selected Patients with Supratentorial Glioblastoma Multiforme (GBM): Report of RTOG 93-05 Protocol.

Randomized Trial on the efficacy of Radiotherapy for Cerebral Low-Grade Glioma in the Adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council Study BR04: An Interim Analysis

Results of the Phase III ENRICH (RT-016) Study of Efaproxiral Administered Concurrently with Whole Brain Radiation Therapy (WBRT) in Women with Brain Metastases from Breast Cancer

Results of Whole Brain Radiation Therapy in Breast Cancer Patients with Brain Metastases

RSR 13 Plus Cranial Radiation Therapy Improves Survival in Patients With Brain Metastases Compared to RTOG Recursive Partitioning Analysis Brain Metastases Database

Secondary Brain Tumors In Children Treated For Acute Lymphoblastic Leukemia At St Jude Children's Research Hospital

Stage 3 Astrocytoma Treatment

Stereotactic Radiosurgery (SRS) Dose Selection for < 2 cm Brain Metastases: The Influence of Planned Whole Brain Radiation Therapy (WBRT)

Stereotactic Radiosurgery for Brain Metastases

Stereotactic Radiosurgery with Whole Brain Radiation Therapy Improves Survival in Patients with Brain Metastases: Report of Radiation Therapy Oncology Group Phase III Study 95-08

Subsequent Quality of Life for Children Irradiated for a Brain Tumor Before Age Four Years

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme

Temozolomide Concomitant and Sequential to Radiotherapy as First Line of Treatment in Glioblastoma Multiforme: An Ongoing Multicentric Phase 2 Trial

Temozolomide for Brain Tumors

The Role of AGT in Guiding Therapy of Malignant Glioma

Treatment for Glioblastoma Multiforme

Treatment for Glioblastoma multiforme

Treatment for Optic Nerve Glioma

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

Whole Brain Radiotherapy Alone or in Combination with Temozolomide (TMZ) for Brain Metastases. A Phase III Study

Current Clinical Trials for Brain Tumors at
The University of Pennsylvania

A Feasibility Assessment and a Phase I/II Trial of MLN518 for Treatment of Patients With Recurrent Glioblastoma

A Phase I Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

A Phase I/II Trial of Hydroxychloroquine in Conjunction With Radiation Therapy and Concurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

A Phase I/II Trial of Temozolomide and ABT-888 in Subjects With Newly Diagnosed Glioblastoma Multiforme

Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B MAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme

Phase 2 Study of Dose-Intense Temozolomide in Recurrent Glioblastoma

Phase I/II Study of the Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Brain Tumors

Radiation Oncology

"Cereport" Treatment for Astrocytoma

7th National Brain Tumor Conference

7th National Brain Tumor Conference

A Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma

A Multicenter, Randomized, Double Blind, Placebo (PB) Controlled Trial of Marimastat (MT) In Patients with Glioblastoma Multiforme (GBM) or Gliosarcoma (GS) Following Completion of Conventional, First-Line Treatment

A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

A Phase II Randomized Trial of Synchronous Radiotherapy With Temozolomide in Brain Metastases

A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma: 5-year Disease Control and Functional Outcomes

A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma: 5-year Disease Control and Functional Outcomes

A Phase III Prospective Randomized Trial Comparing Radiosurgery With Versus Without Whole Brain Radiotherapy for 1-3 Newly Diagnosed Brain Metastases

ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

Brain Tumor Action Week Symposium

Brain tumors & choosing a cancer center

Brain Tumors, High Tension Wires and Other Risk Factors

Brain Tumors: Confronting the Challenge Together

Chemotherapy for Brain Tumors

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM).  Conclusive results of a radomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.

Development of Glioblastoma Multiforme

Dose Escalation in Pediatric Brain Tumors with Radiation Therapy. A dosimetric Evaluation on The Potential Role of Proton Beam Therapy

Extent of Surgical Resection Predicts a Favorable Outcome for Children with Malignant Gliomas

Hereditary Brain Cancer and Glioblastoma Multiforme

Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

Interim report of the JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1-4 brain metastases.

Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone

Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone

Long-Term Neurological Outcome of Childhood Brain Tumors Treated by Surgery Only

Low-Stage Medulloblastoma: Final Analysis of Trial Comparing Standard-Dose With Reduced-Dose Neuraxis Irradiation

Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial.

Motexafin Gadolinium (MGd) Combined With Prompt Whole Brain Radiation Therapy Prolongs Time to Neurologic Progression in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases: Results of a Randomized Phase 3 Trial

Motexafin gadolinium (MGd) combined with whole brain radiation therapy prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis of two randomized phase III trials

NBTF/ALCASE Brain Metastases Patient Teleconference

Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018

Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018

New Chemotherapy Combination Causes Brain Tumors to Regress

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution

P53, EGFR, and PTEN as markers of diagnosis and prognosis in patients with anaplastic glioma enrolled in NCCTG clinical trials

Patient Summary: Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial

Phase III Trial of BCNU Plus Cisplatin (CDDP) Versus BCNU Alone, and Standard Radiation Therapy (SRT) Versus Accelerated Radiation Therapy (ART) in Glioblastoma (GBM) Patients: NCCTG/SWOG Results

Pilocytic astrocytoma

Predictors of Survival for Patients With Brain Metastases: Results of a Randomized Phase III Trial

Preliminary Report of RTOG 9508: A Phase III Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Unresected Brain Metastases

Preliminary Results from a Phase II Trial of Conformal Radiation Therapy for Localized Pediatric Brain Tumors

Primary Care: Stereotactic Radiosurgery Plus Whole Brain Radiotherapy Versus Radiotherapy Alone for Patients with Multiple Brain Metastases

Prognostic Value of Initial Magnetic Resonance Imaging Growth Rates for World Health Organization Grade II Glioma

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Randomized Prospective Comparison of Stereotactic Radiosurgery (SRS) Followed by Conventional Radiotherapy (RT) with BCNU to RT with BCNU Alone for Selected Patients with Supratentorial Glioblastoma Multiforme (GBM): Report of RTOG 93-05 Protocol.

Randomized Trial on the efficacy of Radiotherapy for Cerebral Low-Grade Glioma in the Adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council Study BR04: An Interim Analysis

Results of the Phase III ENRICH (RT-016) Study of Efaproxiral Administered Concurrently with Whole Brain Radiation Therapy (WBRT) in Women with Brain Metastases from Breast Cancer

Results of Whole Brain Radiation Therapy in Breast Cancer Patients with Brain Metastases

Role of Radiation Therapy in the Management of Craniopharyngiomas in Children and Young Adults

RSR 13 Plus Cranial Radiation Therapy Improves Survival in Patients With Brain Metastases Compared to RTOG Recursive Partitioning Analysis Brain Metastases Database

Secondary Brain Tumors In Children Treated For Acute Lymphoblastic Leukemia At St Jude Children's Research Hospital

Stage 3 Astrocytoma Treatment

Stereotactic Radiosurgery (SRS) Dose Selection for < 2 cm Brain Metastases: The Influence of Planned Whole Brain Radiation Therapy (WBRT)

Stereotactic Radiosurgery for Brain Metastases

Stereotactic Radiosurgery with Whole Brain Radiation Therapy Improves Survival in Patients with Brain Metastases: Report of Radiation Therapy Oncology Group Phase III Study 95-08

Subsequent Quality of Life for Children Irradiated for a Brain Tumor Before Age Four Years

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme

Temozolomide Concomitant and Sequential to Radiotherapy as First Line of Treatment in Glioblastoma Multiforme: An Ongoing Multicentric Phase 2 Trial

Temozolomide for Brain Tumors

The Role of AGT in Guiding Therapy of Malignant Glioma

Treatment for Glioblastoma Multiforme

Treatment for Glioblastoma multiforme

Treatment for Optic Nerve Glioma

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

Whole Brain Radiotherapy Alone or in Combination with Temozolomide (TMZ) for Brain Metastases. A Phase III Study

Surgical Oncology

"Cereport" Treatment for Astrocytoma

7th National Brain Tumor Conference

7th National Brain Tumor Conference

A Multicenter, Randomized, Double Blind, Placebo (PB) Controlled Trial of Marimastat (MT) In Patients with Glioblastoma Multiforme (GBM) or Gliosarcoma (GS) Following Completion of Conventional, First-Line Treatment

A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

A Phase II Randomized Trial of Synchronous Radiotherapy With Temozolomide in Brain Metastases

A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma: 5-year Disease Control and Functional Outcomes

A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma: 5-year Disease Control and Functional Outcomes

A Phase III Prospective Randomized Trial Comparing Radiosurgery With Versus Without Whole Brain Radiotherapy for 1-3 Newly Diagnosed Brain Metastases

ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

Brain Tumor Action Week Symposium

Brain tumors & choosing a cancer center

Brain Tumors, High Tension Wires and Other Risk Factors

Brain Tumors: Confronting the Challenge Together

Chemotherapy for Brain Tumors

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM).  Conclusive results of a radomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.

Development of Glioblastoma Multiforme

Dose Escalation in Pediatric Brain Tumors with Radiation Therapy. A dosimetric Evaluation on The Potential Role of Proton Beam Therapy

Extent of Surgical Resection Predicts a Favorable Outcome for Children with Malignant Gliomas

Hereditary Brain Cancer and Glioblastoma Multiforme

Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

Interim report of the JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1-4 brain metastases.

Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone

Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone

Long-Term Neurological Outcome of Childhood Brain Tumors Treated by Surgery Only

Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial.

Motexafin Gadolinium (MGd) Combined With Prompt Whole Brain Radiation Therapy Prolongs Time to Neurologic Progression in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases: Results of a Randomized Phase 3 Trial

Motexafin gadolinium (MGd) combined with whole brain radiation therapy prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis of two randomized phase III trials

NBTF/ALCASE Brain Metastases Patient Teleconference

Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018

Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018

New Chemotherapy Combination Causes Brain Tumors to Regress

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution

P53, EGFR, and PTEN as markers of diagnosis and prognosis in patients with anaplastic glioma enrolled in NCCTG clinical trials

Patient Summary: Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial

Patient Summary: Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial

Phase III Trial of BCNU Plus Cisplatin (CDDP) Versus BCNU Alone, and Standard Radiation Therapy (SRT) Versus Accelerated Radiation Therapy (ART) in Glioblastoma (GBM) Patients: NCCTG/SWOG Results

Pilocytic astrocytoma

Predictors of Survival for Patients With Brain Metastases: Results of a Randomized Phase III Trial

Preliminary Report of RTOG 9508: A Phase III Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Unresected Brain Metastases

Preliminary Results from a Phase II Trial of Conformal Radiation Therapy for Localized Pediatric Brain Tumors

Primary Care: Stereotactic Radiosurgery Plus Whole Brain Radiotherapy Versus Radiotherapy Alone for Patients with Multiple Brain Metastases

Prognostic Value of Initial Magnetic Resonance Imaging Growth Rates for World Health Organization Grade II Glioma

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Randomized Prospective Comparison of Stereotactic Radiosurgery (SRS) Followed by Conventional Radiotherapy (RT) with BCNU to RT with BCNU Alone for Selected Patients with Supratentorial Glioblastoma Multiforme (GBM): Report of RTOG 93-05 Protocol.

Randomized Trial on the efficacy of Radiotherapy for Cerebral Low-Grade Glioma in the Adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council Study BR04: An Interim Analysis

Results of the Phase III ENRICH (RT-016) Study of Efaproxiral Administered Concurrently with Whole Brain Radiation Therapy (WBRT) in Women with Brain Metastases from Breast Cancer

Results of Whole Brain Radiation Therapy in Breast Cancer Patients with Brain Metastases

RSR 13 Plus Cranial Radiation Therapy Improves Survival in Patients With Brain Metastases Compared to RTOG Recursive Partitioning Analysis Brain Metastases Database

Secondary Brain Tumors In Children Treated For Acute Lymphoblastic Leukemia At St Jude Children's Research Hospital

Stage 3 Astrocytoma Treatment

Stereotactic Radiosurgery (SRS) Dose Selection for < 2 cm Brain Metastases: The Influence of Planned Whole Brain Radiation Therapy (WBRT)

Stereotactic Radiosurgery for Brain Metastases

Stereotactic Radiosurgery with Whole Brain Radiation Therapy Improves Survival in Patients with Brain Metastases: Report of Radiation Therapy Oncology Group Phase III Study 95-08

Subsequent Quality of Life for Children Irradiated for a Brain Tumor Before Age Four Years

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme

Temozolomide Concomitant and Sequential to Radiotherapy as First Line of Treatment in Glioblastoma Multiforme: An Ongoing Multicentric Phase 2 Trial

Temozolomide for Brain Tumors

The Role of AGT in Guiding Therapy of Malignant Glioma

Treatment for Glioblastoma Multiforme

Treatment for Glioblastoma multiforme

Treatment for Optic Nerve Glioma

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

Whole Brain Radiotherapy Alone or in Combination with Temozolomide (TMZ) for Brain Metastases. A Phase III Study